Eric Rose, CMO knows prospects. He is buying. We'll see more insiders buying soon. I've topped up with an intention to sell at $2/s. GLTAH
"Mesoblast intends to file the resubmission this quarter, potentially resulting in an approval for
Ryoncil® (remestemcel-L) in the second half of CY2024. "
Source: APPENDIX 4C QUARTERLY ACTIVITY REPORT FOR QUARTER ENDED MARCH 31, 2024
- Forums
- ASX - By Stock
- MSB
- Ann: Appendix 3Y for Eric Rose
Ann: Appendix 3Y for Eric Rose, page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
0.018(1.65%) |
Mkt cap ! $1.218B |
Open | High | Low | Value | Volume |
$1.08 | $1.08 | $1.06 | $974.5K | 909.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 47449 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 102428 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 103426 | 1.070 |
13 | 99370 | 1.065 |
17 | 111880 | 1.060 |
5 | 82075 | 1.055 |
9 | 323466 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 103323 | 12 |
1.085 | 106300 | 11 |
1.090 | 242439 | 11 |
1.095 | 77551 | 9 |
1.100 | 149423 | 21 |
Last trade - 12.30pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |